Sign in with Google. Opens in new tab
bearish
3 Main Debatable Points to Be Discussed in Samsung BioLogics NDR This Week
312 Views20 Oct 2016 22:54
Samsung BioLogics is quite busy with NDR this week. BioLogics executives are doing their best to justify the proposed valuation for BioLogics IPO....
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »Loading
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Samsung BioLogics IPO - Why Investors Are Excited & Concerned01 Nov 2016
- Samsung BioLogics IPO Price Is Set At Highest End (₩136,000) - 3 Points to Consider27 Oct 2016
- Samsung BioLogics' Revised Valuation Based on P/B Multiple27 Oct 2016
- Samsung BioLogics IPO Part 3 - Valuation05 Oct 2016
- Samsung BioLogics IPO Part 2 - Financials04 Oct 2016
x